Resmed Inc. Stock
€218.60
Your prediction
Financial data and news for ResMed
sharewise wants to provide you with the best news and tools for ResMed, so we directly link to the best financial data sources.
Financials
News

ResMed: A Mixed Bag for Investors Amid Rising Competition
Explore the exciting world of ResMed (NYSE: RMD) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential

ResMed: Digital Health Drives Q2 Growth
ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst